# Society Pass Incorporated.: financial statements, quarterly

SOPAQ · OTC · CIK 1817511 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sopaq.md) · [Financials](/companies/sopaq/financials.md) · [Filings](/companies/sopaq/filings.md) · [Insiders](/companies/sopaq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sopaq/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,641 d](/filings/0001213900-24-032944.md) | [1,966](/filings/0001213900-24-043774.md) | [2,187](/filings/0001213900-24-070687.md) | [2,269](/filings/0001213900-24-098697.md) | [1,673 d](/filings/0001213900-25-032266.md) | [1,847](/filings/0001213900-25-045955.md) | [1,711](/filings/0001641172-25-023454.md) | [1,676](/filings/0001493152-25-022564.md) | [1,872 d](/filings/0001213900-25-032266.md) | [1,474](/filings/0001213900-25-045955.md) | [2,501](/filings/0001641172-25-023454.md) | [1,380](/filings/0001493152-25-022564.md) |
| Cost of revenue | $k | [1,967 d](/filings/0001213900-24-032944.md) | [1,280](/filings/0001213900-24-043774.md) | [1,610](/filings/0001213900-24-070687.md) | [1,707](/filings/0001213900-24-098697.md) | [1,029 d](/filings/0001213900-25-032266.md) | [1,354](/filings/0001213900-25-045955.md) | [1,246](/filings/0001641172-25-023454.md) | [1,310](/filings/0001493152-25-022564.md) | [1,332 d](/filings/0001213900-25-032266.md) | [1,008](/filings/0001213900-25-045955.md) | [1,088](/filings/0001641172-25-023454.md) | [493](/filings/0001493152-25-022564.md) |
| Gross profit | $k | [674 d](/filings/0001213900-24-032944.md) | [686](/filings/0001213900-24-043774.md) | [577](/filings/0001213900-24-070687.md) | [563](/filings/0001213900-24-098697.md) | [644 d](/filings/0001213900-25-032266.md) | [493](/filings/0001213900-25-045955.md) | [464](/filings/0001641172-25-023454.md) | [366](/filings/0001493152-25-022564.md) | [540 d](/filings/0001213900-25-032266.md) | [466](/filings/0001213900-25-045955.md) | [1,413](/filings/0001641172-25-023454.md) | [887](/filings/0001493152-25-022564.md) |
| Research and development | $k | [16.4 d](/filings/0001213900-24-032944.md) | [13.9](/filings/0001213900-24-043774.md) | [15.2](/filings/0001213900-24-070687.md) | [12.6](/filings/0001213900-24-098697.md) | [13.9 d](/filings/0001213900-25-032266.md) | [13.5](/filings/0001213900-25-045955.md) | [13.8](/filings/0001641172-25-023454.md) | [13.6](/filings/0001493152-25-022564.md) | [13.7 d](/filings/0001213900-25-032266.md) | [12.9](/filings/0001213900-25-045955.md) | [13.5](/filings/0001641172-25-023454.md) | [13.1](/filings/0001493152-25-022564.md) |
| Operating income | $k | [(9,840) d](/filings/0001213900-24-032944.md) | [(5,450)](/filings/0001213900-24-043774.md) | [(3,416)](/filings/0001213900-24-070687.md) | [(4,143)](/filings/0001213900-24-098697.md) | [(4,952) d](/filings/0001213900-25-032266.md) | [(2,892)](/filings/0001213900-25-045955.md) | [(2,155)](/filings/0001641172-25-023454.md) | [(1,175)](/filings/0001493152-25-022564.md) | [(3,100) d](/filings/0001213900-25-032266.md) | [(1,866)](/filings/0001213900-25-045955.md) | [(153)](/filings/0001641172-25-023454.md) | [(5,245)](/filings/0001493152-25-022564.md) |
| Interest expense | $k | [9.4 d](/filings/0001213900-24-032944.md) | [0.4](/filings/0001213900-24-043774.md) | [0.3](/filings/0001607062-23-000393.md) | [0.3](/filings/0001213900-23-086883.md) | [(0.7) d](/filings/0001213900-24-032944.md) | [0.2](/filings/0001213900-24-043774.md) | [0.3](/filings/0001641172-25-023454.md) | [40.5](/filings/0001493152-25-022564.md) | [111 d](/filings/0001213900-25-032266.md) | [0.2](/filings/0001213900-25-045955.md) | [0.2](/filings/0001641172-25-023454.md) | [0.8](/filings/0001493152-25-022564.md) |
| Income tax | $k | [0.8 d](/filings/0001213900-24-032944.md) | [0.6](/filings/0001213900-24-043774.md) | [1.1](/filings/0001213900-24-070687.md) | [0.7](/filings/0001213900-24-098697.md) | [22.9 d](/filings/0001213900-25-032266.md) | [1.1](/filings/0001213900-25-045955.md) | [3.9](/filings/0001641172-25-023454.md) | [51.8](/filings/0001493152-25-022564.md) | [23.7 d](/filings/0001213900-25-032266.md) | [0.6](/filings/0001213900-25-045955.md) | [0.7](/filings/0001641172-25-023454.md) | [66.6](/filings/0001493152-25-022564.md) |
| Net income | $k | [(9,774) d](/filings/0001213900-24-032944.md) | [(5,295)](/filings/0001213900-24-043774.md) | [(3,315)](/filings/0001213900-24-070687.md) | [(3,862)](/filings/0001213900-24-098697.md) | [(5,662) d](/filings/0001213900-25-032266.md) | [(2,840)](/filings/0001213900-25-045955.md) | [(1,938)](/filings/0001641172-25-023454.md) | [(1,378)](/filings/0001493152-25-022564.md) | [(4,071) d](/filings/0001213900-25-032266.md) | [(1,841)](/filings/0001213900-25-045955.md) | [479](/filings/0001641172-25-023454.md) | [(5,119)](/filings/0001493152-25-022564.md) |
| Diluted EPS | $ per share | not reported | [(3.00)](/filings/0001213900-24-043774.md) | [(1.77)](/filings/0001213900-24-070687.md) | [(2.03)](/filings/0001213900-24-098697.md) | not reported | [(1.21)](/filings/0001213900-25-045955.md) | [(0.73)](/filings/0001641172-25-023454.md) | [(0.48)](/filings/0001493152-25-022564.md) | not reported | [(0.44)](/filings/0001213900-25-045955.md) | [0.10](/filings/0001641172-25-023454.md) | [(0.89)](/filings/0001493152-25-022564.md) |
| Basic EPS | $ per share | not reported | [(3.00)](/filings/0001213900-24-043774.md) | [(1.77)](/filings/0001213900-24-070687.md) | [(2.03)](/filings/0001213900-24-098697.md) | not reported | [(1.21)](/filings/0001213900-25-045955.md) | [(0.73)](/filings/0001641172-25-023454.md) | [(0.48)](/filings/0001493152-25-022564.md) | not reported | [(0.44)](/filings/0001213900-25-045955.md) | [0.09](/filings/0001641172-25-023454.md) | [(0.84)](/filings/0001493152-25-022564.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.9](/filings/0001213900-24-032944.md) | [13.8](/filings/0001607062-23-000263.md) | [10.8](/filings/0001607062-23-000393.md) | [8.2](/filings/0001213900-23-086883.md) | [3.6](/filings/0001213900-25-032266.md) | [1.6](/filings/0001213900-24-043774.md) | [0.8](/filings/0001641172-25-023454.md) | [4.2](/filings/0001493152-25-022564.md) | [7.6](/filings/0001493152-25-022564.md) | [7.1](/filings/0001213900-25-045955.md) | [8.2](/filings/0001641172-25-023454.md) | [6.6](/filings/0001493152-25-022564.md) |
| Current assets | $m | [23.0](/filings/0001213900-24-032944.md) | [16.9](/filings/0001607062-23-000263.md) | [14.6](/filings/0001607062-23-000393.md) | [12.1](/filings/0001213900-23-086883.md) | [7.9](/filings/0001213900-25-032266.md) | [5.5](/filings/0001213900-24-043774.md) | [5.6](/filings/0001213900-24-070687.md) | [9.8](/filings/0001213900-24-098697.md) | [14.5](/filings/0001493152-25-022564.md) | [16.2](/filings/0001213900-25-045955.md) | [22.6](/filings/0001641172-25-023454.md) | [26.6](/filings/0001493152-25-022564.md) |
| Total assets | $m | [32.7](/filings/0001213900-24-032944.md) | [26.1](/filings/0001607062-23-000263.md) | [24.0](/filings/0001607062-23-000393.md) | [20.7](/filings/0001213900-23-086883.md) | [16.4](/filings/0001213900-25-032266.md) | [13.3](/filings/0001213900-24-043774.md) | [13.0](/filings/0001213900-24-070687.md) | [17.0](/filings/0001213900-24-098697.md) | [21.3](/filings/0001493152-25-022564.md) | [22.9](/filings/0001213900-25-045955.md) | [29.2](/filings/0001641172-25-023454.md) | [32.9](/filings/0001493152-25-022564.md) |
| Current liabilities | $m | [11.6](/filings/0001213900-24-032944.md) | [9.4](/filings/0001607062-23-000263.md) | [10.2](/filings/0001607062-23-000393.md) | [9.9](/filings/0001213900-23-086883.md) | [10.4](/filings/0001213900-25-032266.md) | [9.4](/filings/0001213900-24-043774.md) | [10.3](/filings/0001213900-24-070687.md) | [15.9](/filings/0001213900-24-098697.md) | [23.2](/filings/0001493152-25-022564.md) | [23.3](/filings/0001213900-25-045955.md) | [26.5](/filings/0001641172-25-023454.md) | [19.0](/filings/0001493152-25-022564.md) |
| Total liabilities | $m | [12.7](/filings/0001213900-24-032944.md) | not reported | [11.3](/filings/0001607062-23-000393.md) | [10.8](/filings/0001213900-23-086883.md) | [11.3](/filings/0001213900-25-032266.md) | [10.0](/filings/0001213900-24-043774.md) | [10.9](/filings/0001213900-24-070687.md) | [16.4](/filings/0001213900-24-098697.md) | [23.7](/filings/0001493152-25-022564.md) | [23.8](/filings/0001213900-25-045955.md) | [26.9](/filings/0001641172-25-023454.md) | [19.6](/filings/0001493152-25-022564.md) |
| Current portion of debt | $m | [0.0](/filings/0001213900-23-086883.md) | [0.0](/filings/0001607062-23-000263.md) | [0.0](/filings/0001607062-23-000393.md) | [0.0](/filings/0001213900-23-086883.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [20.3](/filings/0001213900-24-032944.md) | [16.0](/filings/0001607062-23-000263.md) | [13.1](/filings/0001607062-23-000393.md) | [10.4](/filings/0001213900-23-086883.md) | [5.3](/filings/0001213900-25-032266.md) | [3.5](/filings/0001213900-24-043774.md) | [2.4](/filings/0001213900-24-070687.md) | [0.9](/filings/0001213900-24-098697.md) | [(2.1)](/filings/0001493152-25-022564.md) | [(0.7)](/filings/0001213900-25-045955.md) | [2.4](/filings/0001641172-25-023454.md) | [13.9](/filings/0001493152-25-022564.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.6) d](/filings/0001213900-24-032944.md) | [(4.0)](/filings/0001213900-24-043774.md) | [(2.9) d](/filings/0001213900-24-070687.md) | [(2.9) d](/filings/0001213900-24-098697.md) | [(4.1) d](/filings/0001213900-25-032266.md) | [(2.4)](/filings/0001213900-25-045955.md) | [(0.9) d](/filings/0001641172-25-023454.md) | [2.0 d](/filings/0001493152-25-022564.md) | [3.7 d](/filings/0001213900-25-032266.md) | [(4.0)](/filings/0001213900-25-045955.md) | [(1.8) d](/filings/0001641172-25-023454.md) | [(16.7) d](/filings/0001493152-25-022564.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001213900-24-032944.md) | [0.2](/filings/0001213900-24-043774.md) | [0.1 d](/filings/0001213900-24-070687.md) | [(0.1) d](/filings/0001213900-24-098697.md) | [0.0 d](/filings/0001213900-25-032266.md) | not reported | not reported | not reported | [0.0 d](/filings/0001213900-25-032266.md) | not reported | not reported | [(0.0) d](/filings/0001493152-25-022564.md) |
| Share repurchases | $m | not reported | [0.5](/filings/0001213900-24-043774.md) | [0.1 d](/filings/0001213900-24-070687.md) | [0.0 d](/filings/0001213900-24-098697.md) | [0.1 d](/filings/0001213900-25-032266.md) | [0.5](/filings/0001213900-25-045955.md) | [0.0 d](/filings/0001641172-25-023454.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.9](/filings/0001607062-23-000263.md) | [24.3](/filings/0001607062-23-000393.md) | [25.3](/filings/0001213900-23-086883.md) | [1.8](/filings/0001213900-24-043774.md) | [1.9](/filings/0001213900-24-070687.md) | [1.9](/filings/0001213900-24-098697.md) | [2.3](/filings/0001213900-25-045955.md) | [2.7](/filings/0001641172-25-023454.md) | [2.9](/filings/0001493152-25-022564.md) | [4.2](/filings/0001213900-25-045955.md) | [5.0](/filings/0001641172-25-023454.md) | [5.7](/filings/0001493152-25-022564.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,105,525 at 2025-11-14, from the cover of the [10-Q filed 2025-11-14](/filings/0001493152-25-022564.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.